Femasys (FEMY) Cash from Operations (2020 - 2026)
Femasys' (FEMY) quarterly Cash from Operations came in at 4143508.0 in Q1 2026, up 13.05% YoY from 3665304.54 in Q1 2025, and up 1.0% on a QoQ basis from 4185240.0 in Q4 2025.
Femasys (FEMY) Cash from Operations (2020 - 2026) Analysis & Trends
Femasys (FEMY) has 7 years of Cash from Operations data on file, last reported at 4143508.0 in Q1 2026.
- Quarterly Cash from Operations rose 13.05% year-over-year to 4143508.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 18068859.0 (up 8.0% YoY) and the FY2025 annual result came in at 18690565.0, up 3.87% from the prior year.
- Cash from Operations rose to 4143508.0 in Q1 2026, from 4185240.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 2379875.0 in Q2 2022 to a low of 5474660.0 in Q3 2024.
- A 5-year average of 3781800.06 and a median of 4143508.0 in 2026 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations sank 137.28% — and 2025, when it climbed 17.53%.
- Tracing FEMY's Cash from Operations over 5 years: stood at 2867887.0 in 2022, then retreated by 5.86% to 3035980.0 in 2023, then sank by 67.15% to 5074569.0 in 2024, then grew by 17.53% to 4185240.0 in 2025, then increased by 1.0% to 4143508.0 in 2026.
- The last three Cash from Operations figures came in at 4143508.0 (Q1 2026), 4185240.0 (Q4 2025), and 5387375.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.27 Bn | 129.05 Bn | 1.96 Bn | 1.06 Bn |
| 2 | Becton Dickinson | 52.49 Bn | 51.63 Bn | 2.32 Bn | 776.00 Mn |
| 3 | Alcon | 35.70 Bn | 34.35 Bn | 1.68 Bn | 510.00 Mn |
| 4 | Resmed | 33.70 Bn | 32.23 Bn | 861.22 Mn | 454.63 Mn |
| 5 | Medline | 29.15 Bn | 26.47 Bn | 2.22 Bn | 715.00 Mn |
| 6 | West Pharmaceutical Services | 25.04 Bn | 24.61 Bn | 329.20 Mn | 124.00 Mn |
| 7 | Solventum | 15.39 Bn | 14.99 Bn | 1.29 Bn | 227.00 Mn |
| 8 | Cooper Companies | 14.79 Bn | 14.65 Bn | 735.40 Mn | 182.80 Mn |
| 9 | Baxter International | 13.59 Bn | 11.44 Bn | 1.03 Bn | 297.00 Mn |
| 10 | Femasys | 9.63 Mn | 8.19 Mn | 189,391.00 | -3.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.14 Mn |
| Mar 31, 2026 | -4.14 Mn |
| Dec 31, 2025 | -4.19 Mn |
| Dec 31, 2025 | -4.19 Mn |
| Sep 30, 2025 | -5.39 Mn |
| Sep 30, 2025 | -5.39 Mn |
| Jun 30, 2025 | -4.35 Mn |
| Jun 30, 2025 | -4.35 Mn |
| Mar 31, 2025 | -4.77 Mn |
| Mar 31, 2025 | -4.77 Mn |
| Dec 31, 2024 | -5.07 Mn |
| Dec 31, 2024 | -5.07 Mn |
| Sep 30, 2024 | -5.47 Mn |
| Sep 30, 2024 | -5.47 Mn |
| Jun 30, 2024 | -4.33 Mn |
| Jun 30, 2024 | -4.33 Mn |
| Mar 31, 2024 | -4.57 Mn |
| Mar 31, 2024 | -4.57 Mn |
| Dec 31, 2023 | -3.04 Mn |
| Dec 31, 2023 | -3.04 Mn |